��������

Steven Glazer is a drug development consultant with experience in providing interim C-suite positions, drug development plans, preclinical and clinical development advice, regulatory affairs, due diligence, and business development. Steven currently holds the position of Chief Medical Officer at Monta Biosciences, Partner at Ventac Partners, and has previous experience as Chief Medical Officer at Allero Therapeutics and RhoVac, among others. Steven holds a Doctor of Medicine degree from the University of Copenhagen.